Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 81-82 巻 1-7 頁 2016 発行
アクセス数 : 980
ダウンロード数 : 0

今月のアクセス数 : 53
今月のダウンロード数 : 0
タイトル
Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
著者
Sakurai Yuuichi
Shiino Madoka
Kudou Kentaro
Nishimura Akira
Miyagi Takuya
Iwakiri Katsuhiko
Umegaki Eiji
Ashida Kiyoshi
収録物名
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
81-82
開始ページ 1
終了ページ 7
収録物識別子
ISSN 0011-393X
EISSN 1879-0313
主題
gastroesophageal reflux; heartburn; NERD; nonerosive gastroesophageal reflux disease; potassium-competitive acid blockers; vonoprazan ( その他)
言語
英語
資源タイプ 学術雑誌論文
出版者
ELSEVIER SCIENCE INC
発行日 2016
アクセス権 メタデータのみ
関連情報
[DOI] 10.1016/j.curtheres.2016.12.001
[PMID] 28119763
備考 This work was supported by Takeda Pharmaceutical Company Limited, manufacturer / licensee of vonoprazan. Medical writing assistance was provided by Elise Magatova, PhD, and Tania Dickson, PhD, of ProScribe - Envision Pharma Group, and was funded by Takeda Pharmaceutical Company Limited. ProScribe's services complied with international guidelines for Good Publication Practice (GPP3).